The seed follow-on round was backed by a consortium including AlbionVC, Delin Ventures, and Playfair Capital.
"Our technology can support healthcare providers in finding appropriate patients to participate in medical research including large scale patient registries which usually demands laborious, manual processes on top of their already complex and heavy workloads."
Future Planet Capital backed the Oxford University spin-out to help hospitals manage infection risks and patient flows.
"Navenio exemplifies our investment thesis; best-in-class innovation from the world’s top university wrapped into a highly commercial product and company with the potential to scale its impact to help billions of lives. Having established partnerships with the NHS, Cleveland Clinic and some of the world’s largest outsourcers, we believe the company is poised to revolutionise healthcare efficiency worldwide. In addition, the core indoor geo-location engine developed at Oxford’s computer science lab, has achieved what competing tech giants in the space have not, and we believe this will be hugely valuable cross-industry."
Scottish business angel syndicate Archangels backs Edinburgh-based Hearing Diagnostics to advance trials and prepare for a 2021 market launch.
"Our vision is for hearing tests to become as accessible and commonplace as eye tests to ensure that everyone with hearing loss receives care at the earliest possible opportunity. Investment by Archangels brings us a huge step towards achieving our vision and we are excited to work with such a highly experienced and supportive group of investors."
The early cancer diagnostic specialist received backing from existing investor Deepbridge Capital alongside leadership changes.
"I am delighted and look forward to working with Martin. We both share the passion for growing businesses which make a difference in people’s lives. These are exciting times as we forge our plans for Zilico"